Bain Capital Trims Stake in Emcure; Kotak MF Bets Big with ₹612 Crore Buy
A notable block deal unfolded in $EMCURE as Kotak Mahindra Mutual Fund acquired 36 lakh shares, representing a 1.89% stake, from BC Investments IV, the investment vehicle of Bain Capital. The transaction, valued at approximately ₹612 crore, was executed at ₹1,700 per share. Following the sale, BC Investments' holding in Emcure is expected to decline from its 3.87% stake reported in March 2026. The deal highlights strong institutional interest in Emcure Pharmaceuticals, while Bain Capital continues its gradual monetization of holdings after the company’s successful market listing. Disclaimer: Investments in securities are subject to market risk. This is for educational purposes only. Investors must verify information before investing and consider their financial position & risk profile.

















